Since increased TGF‐β signalling is required for breast cancer metastasis and CAF‐sEVs suffice to hyperactivate this molecular pathway in breast cancer cells, CAFs are established as a crucial component of the breast TME. This evidence concerns the gene TGFB1 and breast carcinoma.